Please assess the completion status of the following clinical trial:

Trial Title: Xenon Compared to Sevoflurane and Total Intravenous Anaesthesia for Coronary Artery Bypass Graft Surgery

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE3
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* coronary artery disease~* elective surgery, planned coronary artery bypass graft~* moderate hypothermia or normothermia~* cardiac arrest cold and warm cardioplegia~* normal of moderately impaired left ventricular systolic function~* written informed consent~Exclusion Criteria:~* pregnancy or child bearing potential~* ongoing treatment with nicorandil or sulfonylurea medication~* severe renal or hepatic dysfunction~* ongoing myocardial infarction or unstable angina

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Xenon (Type: EXPERIMENTAL): None
- Sevoflurane (Type: ACTIVE_COMPARATOR): None
- Total intravenous anaesthesia (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).